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OBJECTIVES This prospective cohort study of patients with coronary artery disease (CAD) sought to
determine the impact of social support, anger expression and cynical hostility on progression
of coronary atherosclerosis as shown by angiography.
BACKGROUND Low social support, high levels of expressed anger and cynical hostility are correlated to
increased CAD morbidity and mortality. However, the impact of these factors, alone or
together, on progression of human coronary atherosclerosis is unknown.
METHODS Of 223 patients with CAD documented by standardized angiography at baseline, 162 had a
second angiogram after two years. An expert panel who had no knowledge of the patients’
characteristics evaluated the films pairwise to determine disease progression. At baseline, all
patients were asked to answer three self-report questionnaires: questions concerning emo-
tional social support, the State-Trait-Anger-Expression Inventory (STAXI) and the Cook-
Medley cynical hostility scale. Each patient’s clinical and laboratory status was followed.
RESULTS Questionnaires and angiographic follow-up data were available for 150 patients. Bivariate
analysis of the psychological variables showed a higher risk of progression only for patients
who scored high on STAXI anger-out or low on social support. In the multivariate analysis,
when adjusting for confounding variables and examining the interaction between psycholog-
ical variables, only patients with both high anger-out and low social support were at highly
increased risk for progression (odds ratio 30, confidence interval [CI] 5.5 to 165.1; RR 3.19).
CONCLUSIONS Patients with CAD and low emotional social support who express anger outwardly are at a
highly increased risk of disease progression, independent of medication or other risk factors.
(J Am Coll Cardiol 2000;36:1781–8) © 2000 by the American College of Cardiology
Both low social support and high hostility are thought to
increase a person’s risk of developing coronary artery disease
(CAD) and to die from it (1). Direct and indirect patho-
physiologic mechanisms may be involved in this relation.
Both psychological factors have been shown to hyperactivate
neuroendocrine systems, especially the sympathetic nervous
system, and to activate platelets (1). They also promote
adverse health behaviors (1). It is largely unknown, though,
whether these two conditions directly influence atherogen-
esis in human coronary arteries.
Emotional support is probably the component of social
support with the strongest influence on CAD (2,3). Hos-
tility in a wider sense, as it is used here, also has several
components (4). The potential for hostility (i.e., aggressive
verbal or physical responses when angry) was found to be
consistently related to CAD (4–6). The potential for
hostility predicts restenosis (7), and anger predicts recurrent
events, both after percutaneous transluminal coronary an-
gioplasty (PTCA) (8). Suppressed anger, commonly be-
lieved to be harmful, did not predict CAD or all-cause
mortality (4). So-called cynical hostility, as defined by Cook
and Medley, is associated with CAD to a lesser extent; it
can be described as an attitude of resentment, distrust,
cynicism and suspicion (4,9). Some studies suggested that
high hostility and lack of social support may act synergisti-
cally on CAD pathogenesis and expression (10–12).
In the present two-year prospective angiographic study,
we sought to examine our hypothesis that each of the
following psychological characteristics promotes progres-
sion of coronary atherosclerosis in patients with CAD: low
emotional social support, as assessed by the self-report
questionnaires used by Williams et al. (2); experience and
outwardly directed expression of anger, as assessed by the
State-Trait-Anger-Expression Inventory (STAXI) (13);
and cynical hostility, as assessed by the Cook-Medley
hostility scale (9). Furthermore, we hypothesized a positive
interaction between the psychological characteristics.
METHODS
Subjects. Patients were participants in the Study on pre-
vention of Coronary atherosclerosis by Intervention with
Marine Omega-3 fatty acids (SCIMO) trial, a prospective,
randomized, placebo-controlled, double-blind, single-
center study. SCIMO assessed the effect of treatment with
omega-3 fatty acids for two years on coronary atherosclero-
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sis, as demonstrated angiographically. A detailed description
of subjects and methods has been published (14).
All patients (n 5 2,284) referred to our institution
between September 1992 and May 1994 for diagnostic
coronary angiography were screened for eligibility. Patients
whose angiogram demonstrated .20% stenosis in at least
one vessel were eligible, unless they met one of the pre-
defined exclusion criteria (e.g., age .75 years, revascular-
ization in more than one vessel [PTCA or coronary artery
bypass graft operation] planned or already performed in the
preceding six months, hemodynamically relevant left main
coronary artery stenosis or proximal stenosis in all three
main vessels, left ventricular ejection fraction ,35%, history
of cardiac transplantation, diabetes mellitus, psychiatric
disorders) (14). A total of 396 patients were eligible; 338
could be approached; and 223 agreed to participate and gave
informed, written consent that included follow-up coronary
angiography.
The study was approved by the Ethics Committee of the
Faculty of Medicine of the Ludwig-Maximilians-University
of Munich, and was conducted according to the European
Good Clinical Practice guidelines.
Study schedule. History, clinical status, laboratory
work-up and electrocardiogram (ECG) were obtained at the
beginning and after 1, 6, 12, 18 and 24 months. After 24
months, follow-up angiography was performed according to
a highly standardized protocol, as described previously
(14,15).
Assessment of coronary angiograms. Three expert cardi-
ologists who had no knowledge of all possible aspects of the
study, such as treatment, temporal order of the films and
patient characteristics, including psychological status, eval-
uated all pairs of films, working simultaneously. The severity
of all stenoses (percent lumen narrowing) and their relative
clinical significance (e.g., proximal or distal location) was
determined on each film. If one of the three coronary vessels
had had PTCA six months before or any time during the
study period, it was excluded from analysis (16). On the
basis of this evaluation, the global difference between the
baseline and follow-up angiogram was graded semiquanti-
tatively on a scale from 23 to 13, as used in the Cholesterol
Lowering Atherosclerosis Study (CLAS) (15). A score of 0
indicates no difference; 1 indicates a definitely discernible
but small difference; 2 indicates an intermediate difference;
and 3 indicates an extreme difference. Left ventricular
ejection fraction was assessed on the baseline ventriculo-
gram.
The extent of coronary atherosclerosis at the beginning
was defined as the number of stenoses with $50% lumen
narrowing; the clinical severity of the disease was defined as
the number of main vessels with $70% lumen narrowing.
When comparing the follow-up with the baseline angio-
gram, a score of 11, 12 or 13 (small, intermediate or
extreme progression, respectively) was defined as progres-
sion; a score of 0, 21, 22 or 23 (no change, small,
intermediate or extreme regression, respectively) was de-
fined as no progression.
Clinical events were not considered as representing pro-
gression of atherosclerosis because other biologic mecha-
nisms, such as plaque rupture in acute coronary syndromes,
or complex decisions, such as those for PTCA, were
involved. In addition, most PTCAs were either scheduled as
a consequence of the baseline angiogram or were restenoses,
resulting from a different pathomechanism (17).
Assessment of psychological characteristics. At the base-
line visit, all patients received a paper-and-pencil version of
three questionnaires for self-evaluation, were instructed in a
standardized way and were reassured that their answers
would be evaluated anonymously. Emotional social support
was assessed by four questions used in previous research (2)
to measure the functional aspect of emotional social support
(e.g., a person’s perception of his or her relationships as
supportive). This scale has not been psychometrically vali-
dated, but the distribution of answers obtained by Williams
et al. (2) was very similar to ours. A score ranging from 0 to
4 was created by summing the answers (after inversion
where appropriate). The scale was condensed by collapsing
the scores 2 to 4, because of small numbers in these
categories. Thus, a score of 0 indicates a high level of social
support; 1 5 medium level; and 2 to 4 5 low level.
The German version of Spielberger’s STAXI (13,18) was
used to measure angry temperament and angry reaction
(trait anger), as well as forms of anger expression: “anger-
out” denotes an outward direction of anger; “anger-in”
denotes a suppression or nonexpression of angry emotions;
and “anger-control” denotes use of strategies to control
angry emotions. Cynical hostility was measured by the
answers to 50 questions of the German version of the
Minnesota Multiphasic Personality Inventory (MMPI), as
defined by Cook and Medley (9). This is referred to as the
full scale. Barefoot et al. (19) defined three subsets that
altogether predicted mortality better than the full scale:
cynicism, hostile affect and aggressive responding. The sum
of these subsets (19) is referred to as combined subsets.
Questionnaires were considered valid if not more than
Abbreviations and Acronyms
CAD 5 coronary artery disease
CI 5 confidence interval
ECG 5 electrocardiogram or electrocardiographic
HDL 5 high density lipoprotein
LDL 5 low density lipoprotein
OR 5 odds ratio
PTCA 5 percutaneous transluminal coronary
angioplasty
RR 5 risk ratio
SCIMO 5 Study on prevention of Coronary
atherosclerosis by Intervention with Marine
Omega-3 fatty acids
STAXI 5 State-Trait-Anger-Expression Inventory
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one question concerning social support, and each of the
anger (STAXI) scales (13,18), and not more than five
questions concerning cynical hostility were left unanswered
(9).
Data analysis. All analyses were performed using the SPSS
statistical package, version 6.1.1. After the clinical data file
was closed, the sealed envelopes were opened and question-
naires were evaluated by a person who had no knowledge of
the patients’ characteristics, particularly the results of the
expert panel.
Social support was treated as ordinal. Cynical hostility
and STAXI scores were primarily used with no transforma-
tion and treated as quantitative variables.
First, bivariate analysis was performed 1) to examine the
cross-sectional association of all psychological variables with
the baseline characteristics relevant to progression of coro-
nary atherosclerosis and 2) to examine the longitudinal
association of all relevant baseline variables with the out-
come (i.e., CAD progression). The statistical tests appro-
priate to the nature of the data were used (i.e., chi-square
test, Student t test, Mann-Whitney U test). A p value
#0.05 was considered significant.
Second, a multiple logistic regression model with CAD
progression as the dependent variable was built in steps to
identify and adjust for potential confounding variables and
to examine the interaction between psychological variables.
Step 1: Psychological variables (i.e., all scales and subscales)
were selected as independent variables if they were associ-
ated with outcome (CAD progression) in the bivariate
screening procedure at level p # 0.20 (20). Those selected
were forced into the model for further steps. Step 2: To
assess confounding, the change-in-estimate criterion (21)
was used, defined as $10% change in the odds ratio (OR)
of at least one psychological variable forced into the model,
as described earlier. This criterion was chosen to achieve
maximal validity of the relation between psychological
testing and outcome (21,22).
Thirteen potential confounding variables were prese-
lected from all factors known to promote progression of
coronary atherosclerosis: age, gender, positive family history
of premature CAD, marital status, number of stenoses
$50% at baseline, treatment with lipid-lowering drugs and
study medication (omega-3 fatty acids), mean diastolic and
systolic blood pressure, mean high (HDL) and low density
lipoprotein (LDL) cholesterol, mean plasma glucose and
mean number of smoked cigarettes, all during follow-up.
Potential confounding variables were entered into the model
by a forward selection strategy and removed if they did not
meet the change-in-estimate criterion. A p value ,0.05 was
considered to be significant for the association of each
psychological variable with coronary disease progression
after adjustment for confounding. Step 3: The interaction
between psychological variables was examined in the fully
adjusted model. Using the likelihood-ratio test, a p value
,0.05 was defined as significant.
RESULTS
Comparison of patients with and without complete data.
Of 223 patients included in the study, 179 returned a
completed questionnaire. Of these 168 cynical hostility
questionnaires, 166 STAXI trait-anger, 164 anger-out, 164
anger-in and 166 anger-control scales, and 179 social
support ratings were considered valid. A total of 162
patients participated in the study according to the protocol,
including repeat coronary angiography at 24 months. For
150 of them, at least one complete psychological assessment
(cynical hostility, STAXI or social support) could be related
to coronary progression. Patients with complete data did not
differ significantly, in terms of any relevant social, medical
and (as far as information was available) psychological
baseline characteristics, from patients who returned com-
pleted questionnaires but refused follow-up angiography
(n 5 29), those refusing the questionnaires but returning for
angiography (n 5 12) and those who refused both (n 5 32)
(data not shown).
Cross-sectional analysis at baseline. Bivariate analysis
examining the cross-sectional associations between psycho-
logical variables and other baseline characteristics identified
age as the only coronary risk factor that was inversely
correlated with trait-anger (r 5 20.16, p 5 0.041) and
anger-in (r 5 20.22, p 5 0.005).
Among the angiographic findings, cynical hostility (full
scale) and cynical hostility (combined subsets) were signif-
icantly associated with the presence of at least one hemo-
dynamically significant stenosis (.70%) (OR 1.06, 95% CI
1.00 to 1.24 and OR 1.11, 95% CI 1.01 to 1.21 per
increment on the scale, respectively). Lack of social support
correlated with cynical hostility (r 5 0.27, p 5 0.001) and
anger-in (r 5 0.25, p 5 0.003), but not with anger-out.
Bivariate association of baseline data with CAD progres-
sion within two years. A total of 51 patients showed
progression (45 with small and 6 with intermediate progres-
sion); 149 showed no progression (85 with no change, 12
with small and 2 with intermediate regression). Of all
baseline variables, only the number of coronary segments
with $50% stenosis, marital status and, with marginal
significance, mean plasma glucose were able to distinguish
between patients who would progress and those who would
not (Table 1). Patients living with a partner (marital status)
at the beginning of the investigation were more likely to
experience progression on bivariate analysis (Table 1).
The bivariate association of psychological variables at
baseline with CAD progression is presented in Table 2.
Because the magnitude of the OR is dependent on the
number of items in each scale, additionally, the original
numeric scales were transformed into tertiles to facilitate
comparison of ORs. The p values and further variable
selection are based on the original scales. Only low social
support and high anger-out scores were related to progres-
sion.
In a secondary analysis, the semiquantitative score was
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used as the coronary outcome. As for the dichotomous
coronary outcome, among all psychological variables, only
anger-out and social support were associated with the score
(r 5 0.16, p 5 0.057 and r 5 0.16, p 5 0.050, respectively),
and no other variable met the criterion for selection into the
multivariate model.
Two patients had a myocardial infarction, and the angio-
gram of both was classified as showing progression. One
patient had single-vessel bypass surgery and, after excluding
this vessel from the analysis, was classified as showing no
progression. Twenty-eight patients had PTCA. After ex-
clusion of all vessels in which a segment had been dilated
within the study, 21 patients were classified as showing no
progression and seven as showing progression. On univar-
iate analysis, the ORs for progression per increment of the
psychological scales of patients without myocardial infarc-
tion, bypass surgery or PTCA during the study were very
similar to those reported in Table 2: only anger-out (OR
1.12, 95% CI 1.03 to 1.23) and low and medium social
support (OR 1.12, 95% CI 0.45 to 2.82 and OR 4.33, 95%
CI 1.56 to 12.00, respectively) were significantly related to
outcome.
Variable selection in the multivariate model. As a result
of the bivariate screening, only social support and anger-out
met the p , 0.2 selection criterion (Table 2) and were
forced into a multivariate logistic regression model as
psychological variables of interest. Of the 13 potential
confounding variables, only age, marital status, number of
stenoses $50%, high density lipoprotein (HDL) cholesterol
and intake of lipid-lowering drugs met the change-in-
Table 1. Unadjusted Relation Between Biologic, Social and Medical Baseline Characteristics and Overall Change of Coronary
Angiograms After Two Years According to Expert Panel Evaluation
Variable Progression
No
Progression
Odds Ratio
(95% CI)§ Test/p Value
(n 5 51) (n 5 99)
Age (years) 59.3 6 7.5 57.8 6 8.6 1.02 (0.98–1.06) t test/0.269
Gender
Female 7 (25.0%) 21 (75.0%) 0.58 (0.23–1.46) chi-square/2.42
Male 49 (36.6%) 85 (63.4%)
Marital status*
Single, divorced or widowed 5 (17.9%) 23 (82.2%) 0.35 (0.13–0.98) chi-square/0.041
Married or living together 51 (38.1%) 83 (61.9%)
Family history of CAD
Yes 16 (34.8%) 30 (65.2%) 1.07 (0.52–2.21) chi-square/0.682
No 36 (33.3%) 72 (66.7%)
History of hypertension
Yes 31 (39.7%) 47 (60.3%) 1.51 (0.78–2.92) chi-square/0.219
No 24 (30.4%) 55 (69.9%)
Previous myocardial infarction
Yes 28 (31.1%) 62 (68.9%) 0.69 (0.36–1.33) chi-square/0.271
No 28 (39.4%) 43 (60.6%)
Previous PTCA
Yes 31 (33.7%) 61 (66.3%) 0.91 (0.48–1.76) chi-square/0.789
No 25 (35.7%) 45 (64.3%)
Mean body mass index (kg/m2)† 26.3 6 3.0 26.5 6 2.8 0.97 (0.87–1.09) t test/0.656
Mean blood pressure (mm Hg)†
Systolic 139.6 6 10.9 136.5 6 12.8 1.02 0.99–1.05) t test/0.123
Diastolic 83.7 6 5.8 82.2 6 7.3 1.03 (0.98–1.08) t test/0.204
Mean LDL (mmol/liter)† 3.84 6 0.92 3.95 6 0.79 1.00 (0.99–1.01) t test/0.429
Mean HDL (mmol/liter)† 1.31 6 0.32 1.32 6 0.32 1.00 (0.97–1.03) t test/0.876
Mean plasma glucose (mmol/liter)† 6.14 6 1.5 5.71 6 0.96 1.02 (1.00–1.03) t test/0.057
Mean no. of cigarettes/day (all patients)† 1.9 6 4.6 1.5 6 4.7 1.02 (0.95–1.09) t test/0.0638
No. of segments with $50% lumen narrowing* 2.4 6 1.45 1.9 6 1.4 1.27 (1.01–1.60) t test/0.038
No. of main vessels with $70% lumen narrowing* 1.4 6 0.9 1.3 6 0.8 1.23 (0.84–1.80) t test/0.295
Left venricular ejection fraction (%) 60.8 6 6.2 61.6 6 6.9 0.98 (0.94–1.03) t test/0.489
Medication during study
Omega-3 fatty acids
Yes 26 (31.7%) 56 (68.3%) 0.77 (0.40–1.48) chi-square/0.438
No 30 (37.5%) 50 (62.5%)
Hormone replacement therapy (women only)
Yes 1 (12.5%) 7 (87.5%) 0.27 (0.03–37.14) chi-square/0.234
No 7 (35%) 13 (65%)
Lipid-lowering agents‡ 1.5 6 1.9 2.0 6 2.2 0.88 (0.23–1.03) t test/0.093
*At beginning of study. †Mean value per patient from all values obtained during the study. ‡Sum of visits when patients reported being on this drug. §Odds ratio per unit in
univariate logistic regression. Data are presented as the mean value 6 SD or number (%) of patients.
CAD 5 coronary artery disease; CI 5 confidence interval; HDL 5 high density lipoprotein cholesterol; LDL 5 low density lipoprotein cholesterol; PTCA 5 percutaneous
transluminal coronary angioplasty.
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estimate criterion and were controlled for in the final model
(Tables 3 and 4). The remaining eight variables were
removed from the model, regardless of their relation to
progression in the bivariate analysis (Table 1).
Multivariate association of baseline data with CAD
progression within two years. In the logistic regression
model, only social support was significantly related to
progression of coronary atherosclerosis after 24 months.
This relation was independent of CAD extent, as it re-
mained significant when examined separately in patients
with a smaller number (0 to 1) of segments with $50%
stenosis and in patients with a higher number ($2) at
baseline.
Using the fully adjusted model, a second multiple model
was built by adding the interaction term social support
combined with STAXI anger-out (data not shown). This
interaction was significantly related to progression (p 5
0.035).
To describe this effect for distinct groups, the original
social support scale (low, medium and high support) was
combined with two groups obtained by the median split of
the STAXI anger-out scale (#12/$13 score points) (Table
4). The scale was not split to a higher degree to avoid
cell-expected numbers becoming too small. As compared
with patients in the high support/low anger reference group,
patients in the low support/high anger group had an OR of
30 for coronary progression (95% CI 5.5 to 165.1).
Because the OR overestimates the RR (which cannot be
obtained directly by logistic regression analysis) if the
Table 2. Unadjusted Relation Between Psychological Baseline Characteristics and Overall Change in Coronary Angiograms After
Two Years According to Expert Panel Evaluation
Variable Progression
No
Progression
Odds Ratio (95% CI)
per Increment of
Original Scale
Test/p Value
(Original Scale) Score
Odds Ratio
(95% CI) in Tertiles
(Transformed Scales)
Cynical hostility
Full scale 25.0 6 8.8 23.7 6 7.10 1.02 (0.98–1.07) t test/0.362 Low 1
Medium 0.88 (0.37–2.09)
High 1.85 (0.77–4.44)
Cynicism subset 7.8 6 3.6 8.0 6 2.9 0.98 (0.88–1.10) t test/0.742 Low 1
Medium 1.06 (0.48–2.37)
High 1.51 (0.57–3.98)
Hostile affect subset 2.1 6 1.4 1.8 6 1.3 1.19 (0.91–1.55) t test/0.210 Low 1
Medium 0.40 (0.14–1.13)
High 1.97 (0.88–4.40)
Aggressive responding subset 5.1 6 1.7 4.9 6 1.7 1.11 (0.89–1.37) t test/0.358 Low 1
Medium 1.19 (0.46–3.07)
High 1.64 (0.74–3.66)
Combined subsets 15.0 6 5.1 14.7 6 4.5 1.02 (0.94–1.10) t test/0.648 Low 1
Medium 0.95 (0.39–2.33)
High 1.61 (0.71–3.66)
STAXI trait
Anger 20.1 6 5.7 19.7 6 4.8 1.02 (0.95–1.09) t test/0.543 Low 1
Medium 0.98 (0.41–2.46)
High 1.28 (0.55–2.98)
Anger-in 19.0 6 5.1 18.1 6 5.2 1.03 (0.96–1.11) t test/0.369 Low 1
Medium 1.76 (0.75–4.15)
High 1.32 (0.54–3.21)
Anger-out 14.0 6 5.0 12.3 6 3.4 1.11 (1.02–1.21) t test/0.035 Low 1
Medium 0.97 (0.40–2.35)
High 1.70 (0.71–4.05)
Anger-control 23.7 6 5.4 23.3 6 5.3 1.01 (0.95–1.08) t test/0.711 Low 1
Medium 1.25 (0.53–2.98)
High 1.34 (0.56–3.20)
Social support, n (%)
High 23 (27.1%) 62 (72.9%) 1 chi-square/0.0033 Identical with original scale
Medium 10 (27.8%) 26 (72.2%) 1.04 (0.43–2.48)
Low 17 (60.7%) 11 (39.3%) 4.17 (1.70–10.21)
Data indicate score on the respective scales, given as mean 6 SD or number (%).
CI 5 confidence interval; STAXI 5 State-Trait-Anger-Expression Inventory.
Table 3. Adjusted Effect of Social Support and Anger
Expression on Progression of Coronary Atherosclerosis
Variable OR 95% CI
Social support
High 1
Medium 1.77 0.66–4.75
Low 8.30 2.58–26.69
Anger-out (per score point) 1.08 0.97–1.21
Logistic regression model adjusting for age, marital status, number of coronary
stenoses $50% at baseline, mean high density lipoprotein cholesterol and intake of
lipid-lowering drugs during follow-up.
CI 5 confidence interval; OR 5 odds ratio.
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so-called rare disease assumption is not met, as in this case,
the RR was calculated for a median covariate setting (Table
4) (i.e., by calculating the probability of progression for
patients with median values in all covariates (age 58 years,
married, two coronary segments with $50% stenosis, HDL
cholesterol 1.3 mmol/liter, lipid-lowering drugs during six
months of follow-up). For patients in the low support/high
anger group, this translates to a RR of 3.19.
Sensitivity analysis. The potential influence of the 29
patients who dropped out during the study but completed
questionnaires at baseline on the associations presented in
Table 4 was examined by making two extreme assumptions:
1) all patients with high support and low anger (n 5 7,
reference group), but no patients with low support and high
anger (n 5 6, high risk group), had progression; and 2) no
patients with high support and low anger, but all patients
with low support and high anger had progression. Further,
both assumptions were based on that one-third of the
patients in the remaining four medium-risk groups had
progression. For assumption 1, the OR of the high risk
group diminished to 4.96 (CI 1.49 to 16.51); for assumption
2, the OR increased to 62.05 (CI 11.89 to 323.69).
Effect modification by treatment with omega-3 fatty
acids with respect to social support and anger-out was
examined using interaction terms in the logistic regression
model. The effect sizes of the estimated risks associated with
the psychological measures were not different (p 5 0.848)
between the active treatment and placebo groups.
DISCUSSION
This investigation examined, for the first time to our
knowledge, the influence of psychological factors on the
progression of coronary atherosclerosis in a prospective
angiographic study. We demonstrated that low perceived
social support and, to a lesser extent, high outwardly
expressed anger, both reported at baseline, were associated
with accelerated progression within two years of follow-up
in a bivariate analysis. Only when both psychological factors
were present at a high level and acted in concert was this
associated with a markedly elevated risk (OR 30.0, RR 3.19)
in a multivariate analysis controlling for other known risk
factors. For the psychological characteristics—cynical hos-
tility, angry temperament, suppression of anger and control
of anger—there was no significant association with progres-
sion.
Interaction of anger and social support. High anger and
low social support influenced progression of CAD by acting
synergistically (Table 4), as we hypothesized based on
previous observations (10,11). Owing to the prespecified
variable selection process, the interaction of these two but
not of other psychological measures was tested. Dealing
with this issue, there is only one prospective angiographic
study conducted with cynomolgus monkeys, which demon-
strated that destruction of social bonds and thereby induc-
tion of aggression accelerates atherogenesis in coronary
arteries (23). Thus, our study adds weight to the idea that
not one but two personality features, acting jointly, delete-
riously affect the course of CAD, thereby defining the high
risk group more precisely.
Emotional versus structural social support. We found
the association of the emotional quality, as compared with
the structural quality (i.e., being married), of social support
with CAD progression was stronger in bivariate and mul-
tivariate analyses. A recent meta-analysis concluded that the
quality of support, in particular, emotional support, showed
the largest effect on CAD (3). In contrast, the quantity of
support (e.g., social network size, marital status, number of
friends or relatives) was observed to predominantly influ-
ence CAD mortality, possibly reflecting the availability of
quick medical assistance (2,24). For both qualities, the
association with CAD may be different in women (25).
However, in our study, the effect was not modified by
gender.
Cynical hostility. In this study, cross-sectional analysis at
baseline showed an association between cynical hostility and
the presence of significant ($70%) coronary stenosis, but no
association with progression in the two following years.
Two explanations are plausible: our patients scored high on
the cynical hostility scale (mean 24.1, median 24), as
compared with those patients in studies that found an
association (cutpoint 10 [26], mean 16.1 [27] and mean
14.65 [19]). Thus, selection of a highly hostile study group
Table 4. Combined Adjusted Effect of Social Support and Anger Expression on Progression of
Coronary Atherosclerosis
Variable n
No. of Patients
With Progression OR 95% CI Risk Ratio*
High support/low anger 41 9 1 1
High support/high anger 36 9 1.31 0.42–4.11 1.20
Medium support/low anger 19 7 3.03 0.81–11.37 1.91
Medium support/high anger 14 3 0.89 0.18–4.38 0.92
Low support/low anger 10 3 2.19 0.36–13.50 1.63
Low support/high anger 17 14 30.0 5.45–165.06 3.19
*Risk ratio was calculated for median values in age, marital status, number of coronary stenoses $50% at baseline, mean high
density lipoprotein cholesterol and intake of lipid-lowering drugs during follow up. State-Trait-Anger-Expression Inventory
treated as dichotomous variable (median split: #12, .12). Logistic regression model adjusting for age, marital status, number
of coronary stenoses $50% at baseline, mean high density lipoprotein cholesterol and intake of lipid-lowering drugs during
follow-up.
Abbreviations as in Table 3.
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may have made the difference between high and low cynical
hostility undetectable in our study (so-called disease-based
spectrum bias) (4,28). Second, it was recently demonstrated
that increased risk for all-cause mortality, cardiovascular
mortality and nonfatal myocardial infarction of highly
cynical hostile men is primarily mediated through coronary
risk factors (29). Intense treatment of risk factors in our
patients may have leveled off any difference in risk factor
profile between more and less cynically hostile patients.
Definition of coronary outcome. A global change on the
coronary angiograms was assessed visually by an expert
panel using a semiquantitative scale (30). Studies directly
comparing evaluation by the expert panel and by quantita-
tive coronary angiography showed good to excellent agree-
ment for both methods if the change of natural coronary
atherosclerosis (not restenosis after PTCA) was assessed
(31,32). The expert panel appears to be even more superior
if the coronary angiographic change visualized over the
entire coronary artery tree is the outcome of interest (33).
With regard to the published data, we had hypothesized
that the psychological factors studied would promote pro-
gression, and we therefore chose a dichotomous primary
coronary outcome. In a secondary analysis, similar associa-
tions were found for psychological variables with a semi-
quantitative coronary outcome, suggesting that regression,
the type of change that is defined as “no progression” in the
dichotomous outcome, is not differently influenced by the
psychological measures.
Lipids and coronary outcome. Low density lipoprotein
cholesterol levels were not associated with coronary out-
come. This is in accordance with several lipid-lowering trials
that showed only weak and inconsistent correlations be-
tween baseline LDL cholesterol, in-trial LDL cholesterol or
absolute reduction of LDL cholesterol levels and angio-
graphic progression of atherosclerosis (34). The lipid levels
were not exceedingly high in this study, whereas the
correlations are more likely to be found with high baseline
levels (34).
Study limitations. Our predefined hypothesis was tested in
an investigation designed primarily to study the effect of
omega-3 fatty acids on progression of coronary atheroscle-
rosis. This shortcoming has its ethical reasons and charac-
terizes all clinical studies on psychosocial factors that use
invasively measured end points. Our data are observational
by nature because the psychosocial conditions studied can-
not be randomized. Only an intervention trial could achieve
a higher level of evidence. Some of the potential confound-
ing factors were measured during the study because a change
in the angiograms occurred during this time. Previous
studies that found any associations between LDL or HDL
cholesterol and coronary progression found them to be
strongest for lipid levels during the trial (35). Variables
measured during follow-up could be interpreted as both
confounding variables and intermediate steps in the causal
pathway between psychological measures and progression.
In the latter case, we would have underestimated the effect.
Yet, previous studies have found expressed anger and social
support to be associated with CAD independent of standard
risk factors (4,36).
Approximately one-third of the participants had either no
second angiogram or no questionnaire, or neither. Our data
indicate that these participants did not differ in any respect
from the remaining participants. Most people in this group
ended participation within the first month after randomiza-
tion. Thus, it seems very unlikely that outcome (progres-
sion) triggered the selection and led to selection bias. Yet,
scores for lack of social support and for outwardly expressed
anger were (nonsignificantly) higher in patients who refused
a second angiogram. Sensitivity analysis showed that even if
all patients in the low risk group but none in the high risk
group (referring to the results in Table 4) had progression,
the association would be weaker but still significant, indi-
cating robustness of the results against differential selection
bias. Still, we have no psychological questionnaires for 44 of
223 patients, thus somewhat limiting the generalizability.
However, the magnitude of the OR and RR for progression
in the low support/high anger group, as well as the support
from epidemiologic and experimental studies, corroborates
our results.
Conclusions. We identified patients with CAD, charac-
terized by a combination of self-reported high outwardly
expressed anger and low social support, who are at a highly
increased risk (OR 30, 95% CI 5.5 to 165.1; RR 3.19) for
CAD progression. This finding contributes to the under-
standing of the pathogenesis of CAD. Defining a specific
high risk group is a prerequisite for developing a targeted
prevention strategy.
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